Innovating for a Just and Equitable Future in Genomic and Precision Medicine Research.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Addressing Health Disparities through Community Engagement in Artificial Intelligence-Driven Prevention Science.Prevention science : the official journal of the Society for Prevention Research · 2026
   Review
2. Study design and the sampling of deleterious rare variants in biobank-scale datasets.Proceedings of the National Academy of Sciences of the United States of America · 2025
   Article
3. Impact of surgical compliance on survival prognosis of patients with ovarian cancer and associated influencing factors: A propensity score matching analysis of the SEER database.Heliyon · 2024
   Article
4. Genomic Answers for Kids: Toward more equitable access to genomic testing for rare diseases in rural populations.American journal of human genetics · 2024
   Review
5. ACCESS: an empirically-based framework developed by the International Nursing CASCADE Consortium to address genomic disparities through the nursing workforce.Frontiers in genetics · 2023
   Article
6. Spotlighting Structural Constraints on Decisions About Participation in Genomic and Precision Medicine.AJOB empirical bioethics
   Article

Corrections and comments

• Comment on
  Is It Just for a Screening Program to Give People All the Information They Want?2023
• Comment on
  The Promise and Reality of Public Engagement in the Governance of Human Genome Editing Research.2023
• Comment on
  Rare Disease, Advocacy and Justice: Intersecting Disparities in Research and Clinical Care.2023
• Comment on
  Promoting Equality in the Governance of Heritable Human Genome Editing through Ubuntu: Reflecting on a South African Public Engagement Study.2023
• Comment on
  Bounded Justice, Inclusion, and the Hyper/Invisibility of Race in Precision Medicine.2023
• Comment on
  The Other Side of the Self-Advocacy Coin: How For-Profit Companies Can Divert the Path to Justice in Rare Disease.2023
• Comment on
  Narrative Equity in Genomic Screening at the Population Level.2023
• Comment on
  Ethical, Legal, and Social Implications of Genomics Research: Implications for Building a More Racially Diverse Bioethics Workforce.2023
• Comment on
  Critiquing the Critique of Advocacy.2023

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as